REV.1 Engineering® Launches New Website

MURRIETA, Calif. - Jan. 14, 2020 - PRLog -- REV.1 Engineering announced today the launch of their new website at http://rev1engineering.com.

"Our clients are seeking solutions to very specific, highly demanding requirements for solving complex, medical device development challenges," commented Eric Johnson, CEO and co-founder of REV.1.  "We wanted to position our capabilities and information about our disciplined approach in such a way as to make it as easy as possible for our prospects to find the information they need."

Founded in 2008, REV.1 Engineering provides design and development services for minimally invasive technologies used to treat a wide variety of chronic and acute conditions.  Over the past 12 years, REV.1 has delivered more than 140 devices for structural heart, interventional cardiology, neuromodulation, pain management, wound closure and drug/device combination products.

"There simply aren't a lot of design and development firms that consistently operate in the areas of our expertise," added Phillip Burke, COO and co-founder of the company.  "Trying to find the core competencies our clientele seek can be a bit of a slog.  We thought by repositioning our areas of expertise, in a simple-to-navigate, drill-down format, we would help make it easier for people to find the information they require to make solid, strategic decisions.  Good fit is as important to us as it is to our clients."

One differentiating area of expertise with REV.1 is in the design and development of minimally invasive, catheter-based navigation, delivery and anchoring systems.  This area of expertise has proven to translate well into drug/device combination products used for the targeted delivery of precision therapeutics and biologics, too.  The core team of partner advisors at REV.1 averages more than 20 years of experience developing and commercializing these kinds of complex technologies.  This concentration of highly specific, critical expertise is not commonly found throughout the outsourced engineering services industry.

"We are typically working on First of Kind medical devices...devices that we are in the process of inventing in order to meet the technology's clinical, regulatory and cost requirements," said Mr. Johnson.  "When innovation demands invention, the cumulative expertise and experience of our team makes an enormous difference in time to market and return on investment.  What's challenging for many of our prospects is finding the right information and skill sets they need to develop a device that has never existed before.  We hope our new format website will help them cut through the noise and easily navigate the information they require to come to a sound decision."

© 2020, REV.1 Engineering®.